Product Program year 2025 Source: CMS Open Payments

Nexpowder

Device Therapeutic Endoscopy

PDI 08800038405189

Open in the dashboard

General payments

$47,873

659 payments

Research payments

$532,211

52 payments

Through program year 2025, $47,873 in general payments and $532,211 in research payments were reported against Nexpowder (Therapeutic Endoscopy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $15,787 212
2025 Research $245,869 26
2024 General $17,207 303
2024 Research $272,317 25
2023 General $14,879 144
2023 Research $14,025 1

Breakdown

Who paid General payments · program years 2023–2025
  1. Medtronic, Inc. $47,873 659 payments
Top recipients General payments · program year 2025
  1. Dennis Yang Gastroenterology · Orlando, FL $288 2% · 2 payments
  2. John Vargo Gastroenterology · Independence, OH $288 2% · 2 payments
  3. Amit Bhatt Gastroenterology · Cleveland, OH $288 2% · 2 payments
  4. Vivek Kaul Gastroenterology · Rochester, NY $288 2% · 2 payments
  5. Shivangi Kothari Gastroenterology · Rochester, NY $163 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $11,838 79% · 127 practitioners
  2. Internal Medicine $1,109 7% · 12 practitioners
  3. Surgery $363 2% · 6 practitioners
  4. Nurse Practitioner $218 1% · 5 practitioners
  5. Hospitalist $157 1% · 4 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $2,543 16% · 41 recipients
  2. Ohio $1,924 12% · 14 recipients
  3. New York $1,356 9% · 9 recipients
  4. California $1,353 9% · 13 recipients
  5. Illinois $1,223 8% · 19 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

659 general · 52 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record